Development and validation of RAPID: a patient-specific Monte Carlo three-dimensional internal dosimetry platform

AE Besemer, YM Yang, JJ Grudzinski… - Cancer biotherapy & …, 2018 - liebertpub.com
This work describes the development and validation of a patient-specific Monte Carlo
internal dosimetry platform called RAPID (Radiopharmaceutical Assessment Platform for …

[HTML][HTML] Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform

AE Besemer, YM Yang, JJ Grudzinski… - Cancer Biotherapy & …, 2018 - ncbi.nlm.nih.gov
This work describes the development and validation of a patient-specific Monte Carlo
internal dosimetry platform called RAPID (Radiopharmaceutical Assessment Platform for …

[引用][C] Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform

AE Besemer, YM Yang, JJ Grudzinski, LT Hall… - Cancer Biotherapy and …, 2018 - cir.nii.ac.jp
Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional
Internal Dosimetry Platform | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …

Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform.

AE Besemer, YM Yang, JJ Grudzinski… - Cancer Biotherapy & …, 2018 - europepmc.org
This work describes the development and validation of a patient-specific Monte Carlo
internal dosimetry platform called RAPID (Radiopharmaceutical Assessment Platform for …

Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform

AE Besemer, YM Yang, JJ Grudzinski… - Cancer Biotherapy …, 2018 - experts.nebraska.edu
This work describes the development and validation of a patient-specific Monte Carlo
internal dosimetry platform called RAPID (Radiopharmaceutical Assessment Platform for …

Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform

AE Besemer, YM Yang… - Cancer biotherapy …, 2018 - pubmed.ncbi.nlm.nih.gov
This work describes the development and validation of a patient-specific Monte Carlo
internal dosimetry platform called RAPID (Radiopharmaceutical Assessment Platform for …

Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform

AE Besemer, YM Yang, JJ Grudzinski… - Cancer Biotherapy …, 2018 - search.proquest.com
This work describes the development and validation of a patient-specific Monte Carlo
internal dosimetry platform called RAPID (Radiopharmaceutical Assessment Platform for …

Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform.

AE Besemer, YM Yang, JJ Grudzinski… - Cancer Biotherapy & …, 2018 - europepmc.org
This work describes the development and validation of a patient-specific Monte Carlo
internal dosimetry platform called RAPID (Radiopharmaceutical Assessment Platform for …